Table 1

Baseline characteristics

With HF (n=85)Without HF (n=1275)Number of missingsP value
Gender (female)20 (23.5)261 (20.5)00.500
Mean age in years at index infarction (SD)59.9 (10.3)57.2 (10.7)0<0.001
VF at index MI41 (48.2)527 (41.3)00.212
Cardiovascular risk profile
 Mean BMI (SD)26.6 (3.9)26.6 (3.9)610.806
 FH of CVD62 (77.5)817 (65.8)390.032
 Current smoker50 (59.5)767 (61.5)290.718
 Diabetes8 (9.6)94 (7.6)410.502
 Hypertension32 (39)378 (31.3)720.148
 Atrial fibrillation5 (6.1)17 (1.4)580.001
 High cholesterol17 (22.7)378 (32.1)1090.087
FH of sudden death34 (41)330 (26.1)140.006
Angina 48 hours before STEMI37 (45.1)455 (36.6)350.122
Cardiac medication before STEMI
  β-blocker13 (15.7)120 (9.6)240.073
 Statins3 (3.6)133 (10.6)240.041
 Diuretics5 (6.1)79 (6.3)230.943
 ACE inhibitors/ARB11 (13.3)98 (7.8)260.080
 Aspirin/oral anticoagulation9 (10.8)103 (8.2)220.401
  • Numbers in the columns with and without HF denote n (%), unless specified otherwise.

  • ARB, angiotensin receptor blocker; BMI, body mass index; CVD, cardiovascular disease; FH, family history; HF, heart failure; MI, myocardial infarction; STEMI, ST-elevation myocardial infarction; VF, ventricular fibrillation.